Oops! Something went wrong, please try again later.
By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.* This field …
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
A:
The external domain of the receptor is designed to recognize specific molecular markers on a tumor cell and, when this happens, the internal signaling domain of the molecule is...
Save
Share
More
